← Eichor
Condition: Cryptogenic Stroke Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cryptogenic Stroke

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cardiac Assessment for Thrombus Detection in the Heart Using Advanced Imaging (MRI, CT) in ESUS With Left Ventricular Di
Phase N/A · 1 location(s) · Niguarda Hospital · NCT07298122
Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)
Phase N/A · 1 location(s) · Yonsei University · NCT07724171
Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT06749106
Intensive Cancer Screening After Cryptogenic Stroke
NA · 1 location(s) · Ottawa Hospital Research Institute · NCT05733416
Non-Invasive Detection of Right-to-Left Cardiac Shunts
Phase N/A · 1 location(s) · Scripps Health · NCT07420400
Left Atrial Strain and Cryptogenic Stroke
Phase N/A · 1 location(s) · University of Pittsburgh · NCT07224178
The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
NA · 1 location(s) · University of Alberta · NCT07090057
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Phase N/A · 31 location(s) · Biotronik SE & Co. KG · NCT04075084
Internal Microstructure of Patent Foramen Ovale Related to Stroke
Phase N/A · 2 location(s) · China National Center for Cardiovascular Diseases · NCT04686253
Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study
NA · 1 location(s) · Recross Cardio, Inc. · NCT07698951
AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
Phase N/A · 5 location(s) · Inha University Hospital · NCT07347691
Encore PFO Closure Device - The PerFOrm Trial
NA · 8 location(s) · Encore Medical Inc. · NCT05537753
Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.
NA · 14 location(s) · Lifetech Scientific (Shenzhen) Co., Ltd. · NCT05774288
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-
NA · 5 location(s) · Recross Cardio, Inc. · NCT07172464
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic St
NA · 1 location(s) · Josep Rodes-Cabau · NCT04475510
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
NA · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT05565781
Genetic Variants of Annexin A2 and Cryptogenic Stroke
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06880107
Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure
NA · 2 location(s) · Josep Rodes-Cabau · NCT05907694
Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device
NA · 1 location(s) · St. Antonius Hospital · NCT07414446
Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
NA · 1 location(s) · Parc de Salut Mar · NCT06542770
Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke
NA · 1 location(s) · Technical University of Munich · NCT06005233
PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · 42 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05387954
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.